Insider buying
~$5.1K3,894 sh @ $1.32
Traded Nov 21, 2025 · filed the same day
The CEO of Opko Health paid $5.1K out of pocket for Opko Health shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 19, 2025 · Filed Nov 19, 2025
The CEO of Opko Health paid $39K out of pocket for Opko Health shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$39,107
Shares × reported transaction price
$25K–$100K
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 12 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 1.8% of the CEO's reported total pay for fiscal 2024 ($2.16M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-04-30. The proxy names Dr. Phillip Frost as CEO for that year. A size comparison, not a judgement
21 days after results of Oct 29, 2025, 99 days before results of Feb 26, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1.31 on Nov 19, 2025, 10% above its 52-week low and 32% below its high, after a 15% drop over the previous 30 trading days
52-week range $1.19 (Aug 1, 2025) to $1.94 (Mar 5, 2025), 16% of the way up, from 250 adjusted closes. 30 trading days earlier: $1.55 on Oct 8, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.6% | +4.7% | −0.1% |
| 30 days | +2.3% | +5.0% | −2.6% |
| 90 days | −6.2% | +5.2% | −11.3% |
| 180 days | −11.5% | +12.4% | −24.0% |
Past results only. Not a forecast.
Insider buying
Traded Nov 21, 2025 · filed the same day
The CEO of Opko Health paid $5.1K out of pocket for Opko Health shares.
Insider buying
Traded Nov 21, 2025 · filed the same day
The CEO of Opko Health paid $133K out of pocket for Opko Health shares.
Insider buying
Traded Nov 21, 2025 · filed the same day
The CEO of Opko Health paid $257K out of pocket for Opko Health shares.
FROST PHILLIP MD ET AL, CEO & Chairman's past purchases, 90 days after disclosure: 30 buys, median −2.2 pts vs S&P 500, beat it 13 of 30 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.